Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Alliances entities : Abbvie inc. save search
AbbVie and Umoja Biopharma Announce Strategic Collaboration to Develop Novel In-Situ CAR-T Cell Therapies
Published: 2024-01-04 (Crawled : 00:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
abbvie cell biopharma collaboration car-t
AbbVie and Calibr Expand Strategic Collaboration to Advance Several Preclinical and Early-stage Clinical Assets
Published: 2023-07-26 (Crawled : 14:20) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
abbvie preclinical collaboration
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
Published: 2023-01-10 (Crawled : 17:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.35%
H: 0.12%
C: -1.6%
abbvie collaboration immunology biotech mrna
AbbVie, Anima Strike mRNA Deal Worth Up to $582
Published: 2023-01-10 (Crawled : 14:20) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.35%
H: 0.12%
C: -1.6%
deal mrna
AbCellera Continues Partnership Frenzy with AbbVie Antibody Discovery Pact
Published: 2022-12-15 (Crawled : 17:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.59%
H: 0.44%
C: -0.48%
partnership antibody
Despite $2B AML Deal, AbbVie Stops Early Cancer Combo Trial With I-Mab
Published: 2022-08-17 (Crawled : 14:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.79%
H: 0.95%
C: 0.01%
IMAB | $1.82 1.11% 51K
|
Health Technology
|
| O: -4.39%
H: 0.52%
C: -10.37%
aml trial cancer
AbbVie and Sosei Lead Slate of Early August R&D Deals
Published: 2022-08-02 (Crawled : 16:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
AbbVie Unites with Plexium to Leverage Protein Degraders Against Neurological Diseases
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
neurological disease
AbbVie Unites with Plexium to Leverage Protein Degradation Against Neurological Diseases
Published: 2022-04-28 (Crawled : 21:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
neurological disease
Abbvie and Plexium Enter Into Multi-Target Strategic Collaboration To Develop and Commercialize Targeted Protein Degradation Therapies for Neurological Conditions
Published: 2022-04-28 (Crawled : 19:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
collaboration neurological therapy
Off to Stratospheric 2022 Start, AbbVie Announces New Protein Degradation Par...
Published: 2022-04-28 (Crawled : 15:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
AbbVie Pulls Plug on Parkinson’s Partnership With BioArctic
Published: 2022-04-20 (Crawled : 14:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
partnership
Dragonfly Therapeutics Announces Multi-Target Expansion of its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases
Published: 2022-04-20 (Crawled : 13:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
expansion research collaboration therapeutics
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19
Published: 2022-03-15 (Crawled : 13:30) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.11%
H: 2.74%
C: 2.38%
covid-19 treatment research covid collaboration antiviral
Coherus and Junshi Biosciences to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06
Published: 2021-09-16 (Crawled : 23:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.44%
H: 0.47%
C: -0.15%
CHRS | $2.19 0.46% 210K
|
Health Technology
|
| O: -0.7%
H: 2.3%
C: 2.23%
positive results
AbbVie and Calico Announce Second Extension of Collaboration Focused on Aging and Age-Related Diseases
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.0%
H: 0.43%
C: 0.14%
disease collaboration
Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Dosage Strength
Published: 2021-05-26 (Crawled : 21:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.03%
H: 0.18%
C: 0.15%
IRWD | $8.25 2.36% 160K
|
Health Technology
|
| O: 0.84%
H: 0.67%
C: -0.25%
ev
AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
Published: 2020-12-02 (Crawled : 15:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.04%
H: 1.33%
C: 0.95%
therapy partnership drug
Frontier Medicines and AbbVie Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
Published: 2020-12-02 (Crawled : 15:00) - biospace.com/
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.04%
H: 1.33%
C: 0.95%
therapy partnership drug
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.